# FDA Inspection 1194275 - Barry Heller, M.D. - December 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/barry-heller-md/e025e5d3-b369-4654-baea-9b8f8c991fe1
Source feed: FDA_Inspections

> FDA Inspection 1194275 for Barry Heller, M.D. on December 19, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194275
- Company Name: Barry Heller, M.D.
- Inspection Date: 2022-12-19
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1142687 - 2021-05-20](https://www.keypedia.com/records/fda_inspections/barry-heller-md/65f5e157-d178-434f-8464-81b16fc2fb8c)
- [FDA Inspection 971380 - 2016-05-13](https://www.keypedia.com/records/fda_inspections/barry-heller-md/6b36d9b0-216b-4f95-941b-8ac3ca073daa)

Company: https://www.keypedia.com/companies/barry-heller-md/35c6a7b0-23a8-4a2a-8b09-cdf233ea4190

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c